HomeCompareVBLT vs VICI

VBLT vs VICI: Dividend Comparison 2026

VBLT yields 1282.05% · VICI yields 6.52%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VBLT wins by $169777723.45M in total portfolio value
10 years
VBLT
VBLT
● Live price
1282.05%
Share price
$0.16
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$169777724.42M
Annual income
$147,192,786,254,209.56
Full VBLT calculator →
VICI
VICI Properties Inc.
● Live price
6.52%
Share price
$27.32
Annual div
$1.78
5Y div CAGR
44.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$966.2K
Annual income
$607,376.13
Full VICI calculator →

Portfolio growth — VBLT vs VICI

📍 VBLT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVBLTVICI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VBLT + VICI cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
VBLT pays
VICI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VBLT
Annual income on $10K today (after 15% tax)
$108,974.36/yr
After 10yr DRIP, annual income (after tax)
$125,113,868,316,078.12/yr
VICI
Annual income on $10K today (after 15% tax)
$554.58/yr
After 10yr DRIP, annual income (after tax)
$516,269.71/yr
At 15% tax rate, VBLT beats the other by $125,113,867,799,808.42/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VBLT + VICI for your $10,000?

VBLT: 50%VICI: 50%
100% VICI50/50100% VBLT
Portfolio after 10yr
$84888862.69M
Annual income
$73,596,393,430,792.84/yr
Blended yield
86.70%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on VICI right now

VBLT
Analyst Ratings
6
Buy
2
Hold
Consensus: Buy
Price Target
$5.00
+3105.1% upside vs current
Range: $5.00 — $5.00
Altman Z
-19.9
Piotroski
0/9
VICI
Analyst Ratings
20
Buy
6
Hold
Consensus: Buy
Price Target
$31.60
+15.7% upside vs current
Range: $30.00 — $33.00
Altman Z
1.4
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VBLT buys
0
VICI buys
0
No recent congressional trades found for VBLT or VICI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVBLTVICI
Forward yield1282.05%6.52%
Annual dividend / share$2.00$1.78
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%44.3%
Portfolio after 10y$169777724.42M$966.2K
Annual income after 10y$147,192,786,254,209.56$607,376.13
Total dividends collected$168105692.30M$926.2K
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusBuyBuy
Analyst price target$5.00$31.60

Year-by-year: VBLT vs VICI ($10,000, DRIP)

YearVBLT PortfolioVBLT Income/yrVICI PortfolioVICI Income/yrGap
1← crossover$138,905$128,205.13$11,361$941.49+$127.5KVBLT
2$1,812,960$1,664,331.75$13,320$1,481.32+$1.80MVBLT
3$22,241,274$20,301,406.25$16,284$2,405.01+$22.22MVBLT
4$256,561,041$232,762,878.32$21,040$4,071.78+$256.54MVBLT
5$2,783,868,903$2,509,348,588.72$29,209$7,285.49+$2783.84MVBLT
6$28,425,663,485$25,446,923,758.80$44,443$14,006.51+$28425.62MVBLT
7$273,251,611,466$242,836,151,537.34$75,822$29,512.55+$273251.54MVBLT
8$2,474,012,179,526$2,181,632,955,256.89$148,733$69,726.75+$2474012.03MVBLT
9$21,107,418,843,486$18,460,225,811,393.34$344,394$189,413.75+$21107418.50MVBLT
10$169,777,724,416,739$147,192,786,254,209.56$966,234$607,376.13+$169777723.45MVBLT

VBLT vs VICI: Complete Analysis 2026

VBLTStock

Vascular Biogenics Ltd., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. Its programs are based on its vascular targeting system, a gene-based technology targeting newly formed blood vessels; and monocyte targeting technology, an antibody-based technology that enables specifically inhibit monocyte migration for immune-inflammatory applications. The company's lead product candidate is VB-111, a gene-based biologic that is in Phase III clinical trials for the recurrent platinum-resistant ovarian cancer; and Phase II clinical trials treatment of recurrent glioblastoma and colorectal cancer, as well as has completed Phase II clinical trial for the treatment of thyroid cancer. It is also developing VB-601 for various inflammatory indications, and VB-611 for various solid tumors. The company was formerly known as Medicard Ltd. and changed its name to Vascular Biogenics Ltd. in January 2003. Vascular Biogenics Ltd. was incorporated in 2000 and is headquartered in Modi'in, Israel.

Full VBLT Calculator →

VICIREIT

VICI Properties is an experiential real estate investment trust that owns one of the largest portfolios of market-leading gaming, hospitality and entertainment destinations, including the world-renowned Caesars Palace. VICI Properties' national, geographically diverse portfolio consists of 29 gaming facilities comprising over 48 million square feet and features approximately 19,200 hotel rooms and more than 200 restaurants, bars and nightclubs. Its properties are leased to industry leading gaming and hospitality operators, including Caesars Entertainment, Inc., Century Casinos Inc., Hard Rock International, JACK Entertainment and Penn National Gaming, Inc. VICI Properties also owns four championship golf courses and 34 acres of undeveloped land adjacent to the Las Vegas Strip. VICI Properties' strategy is to create the nation's highest quality and most productive experiential real estate portfolio.

Full VICI Calculator →
📬

Get this VBLT vs VICI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VBLT vs SCHDVBLT vs JEPIVBLT vs OVBLT vs KOVBLT vs MAINVBLT vs NNNVBLT vs EPRTVBLT vs ADC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.